Why is Kronox Lab Sciences Ltd ?
1
High Management Efficiency with a high ROE of 30.23%
2
The company is Net-Debt Free
3
Poor long term growth as Net Sales has grown by an annual rate of 6.13% and Operating profit at 9.00% over the last 5 years
4
Positive results in Mar 26
- NET SALES(Q) Highest at Rs 26.13 cr
- PBDIT(Q) Highest at Rs 9.52 cr.
- OPERATING PROFIT TO NET SALES(Q) Highest at 36.43%
5
With ROE of 30.6, it has a Very Expensive valuation with a 6.2 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -12.24%, its profits have risen by 8.2% ; the PEG ratio of the company is 2.5
6
Despite the size of the company, domestic mutual funds hold only 0% of the company
- Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
7
Underperformed the market in the last 1 year
- Even though the market (BSE500) generated negative returns of -0.36% in the last 1 year, its fall in the stock was much higher with a return of -12.24%
How much should you hold?
- Overall Portfolio exposure to Kronox Lab should be less than 10%
- Overall Portfolio exposure to Specialty Chemicals should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Specialty Chemicals)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Kronox Lab for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Kronox Lab
-12.24%
-0.30
40.82%
Sensex
-6.96%
-0.53
13.24%
Quality key factors
Factor
Value
Sales Growth (5y)
6.13%
EBIT Growth (5y)
9.00%
EBIT to Interest (avg)
30.29
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.09
Sales to Capital Employed (avg)
1.01
Tax Ratio
25.92%
Dividend Payout Ratio
7.28%
Pledged Shares
0
Institutional Holding
2.14%
ROCE (avg)
32.02%
ROE (avg)
30.23%
Valuation Key Factors 
Factor
Value
P/E Ratio
20
Industry P/E
44
Price to Book Value
6.03
EV to EBIT
16.66
EV to EBITDA
15.66
EV to Capital Employed
6.55
EV to Sales
5.28
PEG Ratio
2.41
Dividend Yield
0.34%
ROCE (Latest)
36.34%
ROE (Latest)
30.58%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Bullish
Technical Movement
7What is working for the Company
NET SALES(Q)
Highest at Rs 26.13 cr
PBDIT(Q)
Highest at Rs 9.52 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 36.43%
PBT LESS OI(Q)
Highest at Rs 8.82 cr.
PAT(Q)
Highest at Rs 8.00 cr.
EPS(Q)
Highest at Rs 2.16
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Kronox Lab
Net Sales - Quarterly
Highest at Rs 26.13 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 9.52 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 36.43%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 8.82 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 8.00 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 8.00 cr has Grown at 23.7% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 6.47 CrMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 2.16
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)






